All Antibody articles – Page 3
-
BusinessAstraZeneca licenses skin drugs to Leo
Offloading psoriasis and dermatitis antibodies continues AZ’s plan to refocus on fewer therapy areas
-
BusinessNovartis partners with Xencor for cancer antibodies
Deal deepens Novartis’s focus on immuno-oncology
-
Business
BioAtla and Pfizer to collaborate on antibody research
Two-way agreement to share technology and royalties on new cancer drugs
-
-
Business
Amgen seeks injunction to protect patents
Sanofi and Regeneron sued over cholesterol-regulating antibodies
-
NewsDoctors turn to experimental Ebola treatments
Drugs and vaccines untested in humans are being trialled on Ebola patients
-
Business
Merck & Co doubles up on Ablynx research deal
Cancer nanobody R&D partnership could be worth €1.7 billion
-
Business
Roche backs biologics boom
Swiss firm to invest heavily in manufacturing for complex biological drugs
-
Business
Nanobody inflammation drug attracts Abbvie
$840m licensing deal shows support for antibody fragments
-
Business
First biosimilar antibody drugs approved in Europe
European commission gives final approval to generic infliximab copies
-
Business
Biosimilar drugs step up complexity
First generic monoclonal antibodies recommended for approval in Europe
-
News
Regeneron expands, creating 400 new jobs
US biotech firm announces second expansion in six months
-
Business
Bapineuzunab dropped
Development for the Alzheimer’s treatment stopped after clinical tests
-
Business
Three pronged approach puts brakes on US breast cancer
US approval for anti-HER2 therapy Perjeta (pertuzumab) against breast cancer
- Previous Page
- Page1
- Page2
- Page3
- Next Page